M. Belvisi (U.K.): Transduction mechanisms in airway inflammation.
P. Geppeti (Italy): Proteinase-activated receptor-2 and airways.
V. Lagente (France): Selective phosphodiesterase inhibitors as new anti-inflammatory compounds for the treatment of airway diseases.
F.P. Nijkamp (The Netherlands): Neuro-immune interactions in the lung and the role of tachykinins and nerve growth factor.
D. Hay (U.S.A.): Therapeutic opportunities and challenges for NK-3 receptor antagonists.
N. Frossard (France): Increased production of NGF by IL-1b and bronchial hyperresponsiveness.